International Law Office
FDA Proposes Regulatory Framework for Laboratory-Developed Tests
February 22, 2017
In an unusual move, the Food and Drug Administration (FDA) published a discussion paper on January 13, 2017 entitled “Discussion Paper on Laboratory Developed Tests”, which proposes a new regulatory framework for laboratory-developed tests. The discussion paper describes a risk-based approach that differs significantly from the FDA’s initial proposal in a draft guidance document issued in 2014 and reflects a lighter touch for most laboratory-developed tests.
得意分野
Suggested News & Insights
Exclusive Fireside Chat: A Conversation With FDA's Chief CounselTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026Sidley Represents Dechra in Acquisition of Gallant PetNovember 18, 2026Sidley Represents Sino Biopharmaceutical in its US$7 Billion Licensing Agreement With Boehringer IngelheimNovember 9, 2026Sidley Celebrated as the “Law Firm of the Year” in Two Areas by Best Lawyers: FDA Law and Securities RegulationNovember 5, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory